Moshirfar Majid, Bhavsar Udit M, Durnford Kathryn M, McCabe Shannon E, Ronquillo Yasmyne C, Lewis Adam L, Hoopes Phillip C
HDR Research Center, Hoopes Vision, University of Utah Health Sciences Center, 11820 S. State Street Suite #200, Draper, UT, 84020, USA.
Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah School of Medicine, Salt Lake City, UT, USA.
Ophthalmol Ther. 2021 Sep;10(3):677-689. doi: 10.1007/s40123-021-00358-x. Epub 2021 Jun 15.
Transient dry eye symptoms have been reported following laser in situ keratomileusis (LASIK). Very rarely, patients may present with debilitating symptoms of dry eye syndrome (DES) with limited or no evidence of ocular surface disease. These patients are diagnosed with a form of DES known as neuropathic corneal pain (NCP).
This study is a retrospective medical record review of a case series of 18 patients who developed NCP post-LASIK over the years 1996-2021. All patients who developed severe ocular pain following LASIK consistent with NCP were included. Patients with severe ocular pain who had evidence of severe ocular surface disease or other ophthalmic etiology to explain their debilitating symptoms were not included.
The average age of patients in our study was 39.5 years. The majority of our patients were female (72.2%) and of Caucasian ancestry (83.3%). The average onset of symptoms was 9.6 months post-LASIK. Patients had past medical histories significant for neuropsychiatric conditions (50%), functional pain syndromes (22.2%), autoimmune diseases (33.3%), and hypothyroidism (27.8%), and the occurrence of these was higher than the national prevalence of these diseases. Symptoms were consistent with the severity and characteristics defining NCP. Treatment was multimodal, involved topical and systemic therapies, and was unique to each patient. Overall, the majority of patients had clinical improvement in symptoms following treatment with regular follow-up.
Although rare, the 26-year prevalence of NCP post-LASIK in our study was roughly 1 in 900 cases. The mean time to onset after surgery was delayed at 9.6 months. Certain risk factors such as neuropsychiatric conditions, history of functional pain syndromes, history of autoimmune conditions, and hypothyroidism may predispose patients to the development of this condition. Patients benefited from proper diagnosis and a multimodal approach to treatment.
准分子原位角膜磨镶术(LASIK)后曾有短暂干眼症状的报道。极少数情况下,患者可能出现干眼综合征(DES)的使人衰弱的症状,而眼表疾病证据有限或没有。这些患者被诊断为一种称为神经性角膜疼痛(NCP)的DES形式。
本研究是一项对1996年至2021年间18例LASIK术后发生NCP的病例系列的回顾性病历审查。纳入所有LASIK术后出现与NCP一致的严重眼痛的患者。有严重眼表疾病证据或其他眼科病因来解释其使人衰弱症状的严重眼痛患者未纳入。
我们研究中患者的平均年龄为39.5岁。大多数患者为女性(72.2%),且为白种人血统(83.3%)。症状的平均发作时间为LASIK术后9.6个月。患者有神经精神疾病(50%)、功能性疼痛综合征(22.2%)、自身免疫性疾病(33.3%)和甲状腺功能减退症(27.8%)的既往病史,且这些疾病的发生率高于全国患病率。症状与定义NCP的严重程度和特征一致。治疗是多模式的,包括局部和全身治疗,且因患者而异。总体而言,大多数患者经治疗并定期随访后症状有临床改善。
尽管罕见,但我们研究中LASIK术后NCP的26年患病率约为900例中有1例。术后平均发病时间延迟至9.6个月。某些危险因素,如神经精神疾病、功能性疼痛综合征病史、自身免疫性疾病病史和甲状腺功能减退症,可能使患者易患此病。患者从正确诊断和多模式治疗方法中受益。